Mumbai: Vaccination suspended for 3 days as stocks run out
India | April 30, 2021 8:43 ISTBMC has said that no vaccination against Covid-19 will be held in Mumbai for the three days -- Friday, Saturday and Sunday.
BMC has said that no vaccination against Covid-19 will be held in Mumbai for the three days -- Friday, Saturday and Sunday.
Delhi Chief Minister Arvind Kejriwal announced on Thursday that a plan had been formulated to vaccinate all adults against coronavirus within the next three months.
Covaxin vaccine maker Bharat Biotech on Thursday announced a drop in the price of its vaccine that will be made available to the state governments.
Delhi recorded 368 more COVID-19 deaths and 25,986 cases with a positivity rate of 31. 76 per cent, according to the latest bulletin issued by the city health department. This was the seventh day on the trot that Delhi had recorded over 300 deaths due to coronavirus.
Rahul Gandhi has been demanding free Covid-19 vaccination for all citizens. They have also termed the centre's new vaccination policy discriminatory.
People form long queues outside BKC jumbo COVID-19 vaccination centre in Mumbai. The vaccine centre received 5000 doses of vaccine today and vaccination will start shortly at the centre.
The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.
Registration for the new eligible population groups (all those above 18 years) will start on Wednesday from 4 pm. Vaccination against COVID-19 began in the country on January 16.
The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus. The other two vaccines are Covaxin and Covishield.
The move has come days ahead of India's planned drive to inoculate all aged above 18. The vaccination drive is set to begin May 1.
The pre-clinical trial of the nasal Covid-19 vaccine candidate, BBV154 has already started. If all goes as expected, the clinical trial would be completed by June and it could become available in the market by August.
Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on Sunday.
The Biden administration has come under criticism from several quarters, including from members and supporters of the Democratic party, for not releasing surplus COVID-19 vaccines to India.
Covaxin, India's indigeniously developmed coronavirus vaccine, will be sold at Rs 600 per dose for state hospitals and Rs 1,200 per dose for private hospitals, vaccine maker Bharat Biotech has informed.
India has administered 14 crore doses of COVID-19 vaccine in just 99 days, the fastest in the world, the Health Ministry said on Saturday. More than 24 lakh vaccine doses were administered on Saturday till 8 pm, the ministry said.
Covaxin, India's indigeniously developmed coronavirus vaccine, will be sold at Rs 600 per dose for state hospitals and Rs 1,200 per dose for private hospitals, vaccine maker Bharat Biotech has informed.
Govt Principal Secy (Covid Management and Vaccination) wrote letters to Bharat Biotech MD Krishna Yella and Serum Institute of India Limited CEO Adar Poonawalla in this regard.
Prime Minister Narendra Modi has cancelled his visit to the poll-bound West Bengal on Friday where he was scheduled to address election rallies ahead of the seventh phase of the assembly elections. The Prime Minister will be chairing a high-level meeting to view the pandemic situation.
More than 1,700 doses of Covishield and Covaxin were stolen in Jind district of Haryana. The theft took place at the Jind Civil Hospital.
Top News
Latest News
